24 May 2013
Keywords: vivus, posts, 10m, 4th-qtr, profit, drugmaker, says
Article | 24 March 2008
US drugmaker Vivus says that an increase in revenue, up 259% to $29.8 million following the recognition of $20.9 million in deferred licensing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.